Home/Filings/4/0001735276-24-000096
4//SEC Filing

Hesslein Robert W. 4

Accession 0001735276-24-000096

CIK 0001178670other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:11 PM ET

Size

5.2 KB

Accession

0001735276-24-000096

Insider Transaction Report

Form 4
Period: 2024-10-01
Hesslein Robert W.
EVP, CLO and Secretary
Transactions
  • Award

    Common Stock

    2024-10-01+7,2457,245 total
Footnotes (1)
  • [F1]These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest over a three-year period, with one third vesting on each of the first, second and third anniversaries of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date.

Issuer

ALNYLAM PHARMACEUTICALS, INC.

CIK 0001178670

Entity typeother

Related Parties

1
  • filerCIK 0001585018

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:11 PM ET
Size
5.2 KB